N@N

Market Maker Surveillance Report. SSY, BONA, CSUN, CBLI, HALO, BPAX, Winning Stocks With Lowest Price Friction For Friday, Sep

September 21, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 4058 companies with "abnormal" market making, 3311 companies with positive Friction Factors and 2221 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Sunlink Health Systems Inc (AMEX:SSY), Bona Film Group Ltd (NASDAQ:BONA), China Sunergy Co Ltd (NASDAQ:CSUN), Cleveland BioLabs Inc (NASDAQ:CBLI), Halozyme Therapeutics Inc (NASDAQ:HALO), BioSante Pharmaceuticals Inc (NASDAQ:BPAX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  SSY     $0.230    19.01%    68,894       32.23%    63,298       29.61%    5,596        243     
  BONA    $0.850    17.00%    73,489       71.20%    29,623       28.70%    43,866       516     
  CSUN    $0.180    16.67%    93,739       63.16%    54,675       36.84%    39,064       2,170   
  CBLI    $0.400    15.94%    358,119      59.13%    247,326      40.84%    110,793      2,770   
  HALO    $1.550    24.18%    2,396,651    50.39%    2,305,523    48.48%    91,128       588     
  BPAX    $0.270    16.07%    1,224,054    57.60%    892,229      41.98%    331,825      12,290  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows SSY with a dollar gain Friday of $0.23000 and a Friction Factor of 243 shares. That means that it only took 243 more shares of buying than selling to move SSY higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Sunlink Health Systems Inc (AMEX:SSY) - SunLink Health Systems, Inc., together with its subsidiaries, provides healthcare services in rural and exurban markets in the United States. It operates in two segments, Healthcare Facilities and Specialty Pharmacy. The Healthcare Facilities segment operates 7 community hospitals that consist of 402 licensed beds; 3 nursing homes, which have of 261 licensed beds; and 1 home health agency. The Specialty Pharmacy segment offers specialty and institutional pharmacy services; and durable medical equipment, as well as operates 3 retail pharmacies that provide various products and services. The company was founded in 1959 and is based in Atlanta, Georgia..

Bona Film Group Ltd (NASDAQ:BONA) - Bona Film Group Limited distributes films in the Peoples Republic of China. It distributes films to movie theaters, as well as to non-theatrical distribution channels, including DVD and Blu-ray and other home video products; Internet and digital distribution; in-flight entertainment; and cable, satellite, and broadcast televisions. The company also invests in the production of Chinese and Hong Kong films in order to obtain the distribution rights for movie theaters and non-theatrical channels. In addition, Bona Film Group operates six movie theaters in five cities of the Peoples Republic of China; operates a talent agency business that represents artists; and involves in film advertising and television production businesses. The company was founded in 2003 and is headquartered in Beijing, the Peoples Republic of China..

China Sunergy Co Ltd (NASDAQ:CSUN) - China Sunergy Co., Ltd., together with its subsidiaries, engages in the design, development, manufacture, and sale of solar cells. It manufactures solar cells from silicon wafers utilizing crystalline silicon solar cell technology to convert sunlight directly into electricity through the photovoltaic effect process. The company offers monocrystalline silicon and multicrystalline silicon solar cells. China Sunergy sells its solar cells primarily to module manufacturers and system integrators; and outsources to third parties. It offers its products primarily in Germany, Italy, Spain, the Peoples Republic of China, India, South Korea, and Australia. The company was founded in 2004 and is based in Nanjing, the Peoples Republic of China..

Cleveland BioLabs Inc (NASDAQ:CBLI) - Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses. The companys products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and intestine; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, small molecules that are intended to destroy tumor cells by simultaneously targeting two regulators of apoptosis. Cleveland Biolabs has strategic alliance with The Cleveland Clinic Foundation; a research agreement with Roswell Park Cancer Institute to develop its cancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of approximately 1,000,000 compounds; and a cooperative research and development agreement with the Armed Forces Radiobiology Research Institute. The company was founded in 2003 and is headquartered in Buffalo, New York..

Halozyme Therapeutics Inc (NASDAQ:HALO) - Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets. Its portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. The companys Enhanze technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. It has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. to apply Enhanze Technology to Roches biological therapeutic compounds for up to 13 targets; and with Baxter Healthcare Corporation to apply Enhanze Technology to Baxters biological therapeutic compound, GAMMAGARD LIQUID, as well as to develop and supply active pharmaceutical ingredient for HYLENEX, a product used as an adjuvant to increase the dispersion and absorption of other injected drugs and fluids. The company was founded in 1998 and is based in San Diego, California..

BioSante Pharmaceuticals Inc (NASDAQ:BPAX) - BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. Its lead products include LibiGel (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) special protocol assessment; and Elestrin (estradiol gel) for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, which is marketed in the U.S. by Azur Pharma, BioSantes licensee. The company is also developing a portfolio of cancer vaccines, three of which have been granted orphan drug designation, and are currently in various Phase II clinical trials. Its other products in development comprise Bio-T-Gel, a testosterone gel for male hypogonadism, or testosterone deficiency in men, which is licensed to Teva Pharmaceuticals; and The Pill-Plus that is a combination of estrogens, progestogens, and androgens for the treatment of female sexual dysfunction in women using oral or transdermal contraceptives, in Phase II clinical development using BioSante patented technology. In addition, the company is developing its calcium phosphate technology for aesthetic medicine, as well as seeking opportunities for its 2A/Furin and other technologies. BioSante Pharmaceuticals, Inc. was founded in 1996 and is based in Lincolnshire, Illinois..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net